Interventional technology firm Medtronic of Minneapolis has moved to acquire cryotherapy product developer CryoCath Technologies, the company said.
Medtronic will make a takeover bid for CryoCath's outstanding shares for a total equity value of $380 million. The acquisition is expected to close in the fourth quarter of this year, according to Medtronic.
Related Reading
Medtronic wins Japanese clearance for cardiac monitor, July 15, 2008
Medtronic shuffles management team, April 30, 2008
MediGuide, Medtronic ink deal, January 28, 2008
Medtronic to begin testing MRI-safe pacemaker, January 28, 2008
Medtronic launches stent graft product, January 10, 2008
Copyright © 2008 AuntMinnie.com
